Project Grant HT94252510239
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$778K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award for $506,632.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is intended to support the "ACCELERATING POST-TRAUMATIC EPILEPSY RESEARCH THROUGH DATA INTEGRATION AND VERIFIABLE ANALYSIS AT SCALE" initiative. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
The federal Project Grant award of $946,873.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to investigate the genetic risk of prostate cancer in self-identified Black veterans. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research university and academic medical center in Philadelphia. The research...
The federal Project Grant award for "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $860,998 award to The Regents of the University of California, San Francisco (UCSF) supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will investigate...
The Project Grant award, titled "PROGRAM TO CHARACTERIZE EVOLVING ENDOPHENOTYPES OF DEGENERATION AFTER TRAUMATIC BRAIN INJURY (PROCEED-TBI)", was provided by the Defense Health Agency for $7,956,997.00 with a period of performance from September 30, 2023 to September 29, 2027. The grant supports biomedical research related to the Military Medical Research and Development program (CFDA 12.420), with a focus on characterizing clinically relevant animal models of traumatic brain injury...
This federal Project Grant award of $707,436.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate "Biomarker Signatures of Post-Traumatic Epileptogenesis (PTEGenesis) and Its Treatments". The primary awardee is the Albert Einstein College of Medicine, a private non-profit educational institution, which is conducting this advanced biomedical research. The project includes a sub-award to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,159,317.00 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to support the "EDISYN-LFS: EARLY DETECTION IN SYNDROMIC NEOPLASMS FOR PATIENTS WITH LI FRAUMENI SYNDROME" research project. The award, effective July 1, 2025 through June 30, 2029, will fund advanced...